Results 111 to 120 of about 25,343 (258)

New‐Onset Psychosis in a Person with Parkinson's Disease after “Horny Goat Weed” Use

Movement Disorders Clinical Practice, EarlyView.
Juan R. Deliz, Kasra Manoocheri, Danielle N. Larson, Danny Bega   +3 more
wiley   +1 more source

MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia

EBioMedicine, 2017
In 2009 the U.S. Food and Drug Administration (FDA) placed a black box warning on metoclopramide (MCP) due to the increased risks and prevalence of tardive dyskinesia (TD). In this study, we developed a multi-step biomedical informatics screening (MSBIS)
Dong Xu, Alexandrea G. Ham, Rickey D. Tivis, Matthew L. Caylor, Aoxiang Tao, Steve T. Flynn, Peter J. Economen, Hung K. Dang, Royal W. Johnson, Vaughn L. Culbertson   +9 more
doaj   +1 more source

Cannabinoids and Dementia: A Review of Clinical and Preclinical Data [PDF]

, 2010
The endocannabinoid system has been shown to be associated with neurodegenerative diseases and dementia. We review the preclinical and clinical data on cannabinoids and four neurodegenerative diseases: Alzheimer’s disease (AD), Huntington’s disease (HD),
Aarsland, Aiken, Allen, Aso, Bal-Price, Bambico, Basavarajappa, Bellocchio, Benito, Benito, Blennow, Breivogel, Campbell, Campillo, Cao, Carroll, Centonze, Cernak, Citron, Consroe, Consroe, Cummings, Curtis, Curtis, Curtis, de Lago, De March, Denovan-Wright, Di Marzo, Di Marzo, Ehrhart, Esposito, Esposito, Esposito, Esposito, Eubanks, Fernandez-Espejo, Fernandez-Ruiz, Ferri, Fox, Gaoni, Garcia-Arencibia, Gerdeman, Gilgun-Sherki, Glass, Glass, Glass, Glass, Grunblatt, Gubellini, Hansen, Hayakawa, Herkenham, Hillard, Howlett, Howlett, Iuvone, Iuvone, Jimenez-Del-Rio, Katona, Katona, Katona, Kelsey, Khaspekov, Kirshner, Krishnan, Kumar, Lastres-Becker, Lastres-Becker, Lastres-Becker, Lastres-Becker, Lastres-Becker, Lastres-Becker, Lastres-Becker, Lees, Leker, Leys, Louw, Maneuf, Mangieri, Marchalant, Marchalant, Maresz, Marsicano, Matsuda, Mauler, McCaw, Meschler, Mesnage, Michael Halpern, Milton, Molina-Holgado, Morgese, Muller-Vahl, Munro, Murillo-Rodriguez, Murillo-Rodriguez, Nagayama, Pacher, Palazuelos, Parmentier-Batteur, Passmore, Pavese, Pellegrini-Giampietro, Pertwee, Price, Ramirez, Richfield, Sapp, Savva, Sebastian Walther, Shen, Shen, Sieradzan, Silverdale, Staekenborg, Tai, Tolon, van der Stelt, van der Stelt, van Vliet, Venderova, Volicer, Walker, Walsh, Walter, Walther, Wegener, Westlake, Wilson, Zani, Zhu, Zuardi   +132 more
core   +2 more sources

A case of levosulpiride-induced tardive dyskinesia

Open Journal of Psychiatry and Allied Sciences, 2019
Levosulpiride is chemically a substituted benzamide which acts as an atypical antipsychotic and prokinetic agent. There is dearth of study and limited research on levosulpiride-induced tardive dyskinesia (TD) and its abuse potential till date ...
Soumitra Ghosh, Sandipan Nayek
doaj   +1 more source

Drug-induced dyskinesia when taking Fluvoxamine

Neurology, Neuropsychiatry, Psychosomatics
Drug-induced movement disorders (DIMD) are a significant problem in clinical practice, especially in the context of the use of psychotropic drugs. These disorders can significantly worsen the quality of life of patients and lead to additional difficulties in the treatment of the underlying disease.
A. A. Katok, D. M. Khasanova, I. A. Khasanov   +2 more
openaire   +1 more source

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background As Parkinson's disease (PD) progresses, motor fluctuations become increasingly difficult to manage with oral medications. Foslevodopa/foscarbidopa (LDp/CDp), delivered as a continuous 24‐h/day subcutaneous infusion, offers continuous levodopa delivery and stable plasma levodopa levels that reduce motor fluctuations. LDp/CDp has been
K. Ray Chaudhuri, Bruno Bergmans, Eric Freire‐Alvarez, Lucie Hopes, Drew S. Kern, Robert S. Kirsner, Giulia Lazzeri, Pedro Mendes‐Bastos, Noriko Nishikawa, Per Odin, Karolina Poplawska‐Domaszewicz, Rajesh Pahwa, Yuval Ramot, Klaus Seppi, Tobias Warnecke, Robert Wiggins, Megha B. Shah, Pavnit Kukreja, Bjoern Fritz, Koray Onuk, Stuart H. Isaacson   +20 more
wiley   +1 more source

Pallidal versus subthalamic nucleus deep brain stimulation for levodopa‐induced dyskinesia

Annals of Clinical and Translational Neurology, 2020
Objective To compare the efficacy of subthalamic nucleus (STN) and globus pallidus internus (GPi) deep brain stimulation (DBS) on reducing levodopa‐induced dyskinesia (LID) in Parkinson’s disease, and to explore the potential underlying mechanisms ...
Shi‐Ying Fan, Kai‐Liang Wang, Wei Hu, Robert S. Eisinger, Alexander Han, Chun‐Lei Han, Qiao Wang, Shimabukuro Michitomo, Jian‐Guo Zhang, Feng Wang, Adolfo Ramirez‐Zamora, Fan‐Gang Meng   +11 more
doaj   +1 more source

An Unusual Motor OFF in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Shreyashi Jha, Mandar S. Jog
wiley   +1 more source

Berberis vulgaris alleviates Levodopa-induced dyskinesia in male mice

Herba Polonica, 2018
Introduction: Parkinson’s disease is a chronic debilitating disease and many patients use Levodopa as a major treatment. However, this drug in long-term use causes a serious condition that is known as Levodopa-induced dyskinesia (LID). Berberis vulgaris (
Mokarian Faezeh, Famitafreshi Hamidreza, Jahromy Mahsa Hadipour   +2 more
doaj   +1 more source

Resolution of Levodopa/Dopa‐Decarboxylase Inhibitor—Associated Microscopic Colitis with Subcutaneous Foslevodopa/Foscarbidopa: A Case Series and Review of the Literature

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Microscopic colitis (MC) typically presents with chronic, non‐bloody watery diarrhea. Diagnosis requires endoscopy with colonic mucosal biopsies. The etiology is multifactorial, with several medications implicated, although only a few cases have been attributed to oral levodopa/dopa‐decarboxylase inhibitor (LDDCI) therapy.
Romana Hintner, Franziska Eberhardt, Manuela Kofler, Andreas Eigentler, Atbin Djamshidian, Florian Krismer, Anton Hittmair, Heinz Zoller, Valentina Ellinger, Beatrice Heim, Klaus Seppi   +10 more
wiley   +1 more source